Rhinitis, Allergic, Seasonal — Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)
Citation(s)
Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Intermittent Allergic Rhinitis (IAR)